TFSA Investors: 3 TSX Stocks I’d Buy for 2020

It’s that time again at year end, when investors have to think about rebalancing their portfolios, chucking out underperformers, and adding some growth candidates and stable dividend income generation stocks to create long-term, outperforming TFSA retirement portfolios. Growing a retirement nest egg shouldn’t be too much of a hustle, as the TSX offers some of the most compelling stable growth…

Read More

Why Did Canopy Growth (TSX:WEED) Stock Gain Almost 20% Yesterday?

Shares of Canada’s top cannabis company, Canopy Growth (TSX:WEED)(NYSE:CGC) rose close to 20% on November 20, 2019. The stock lost 33% in market value between November 8 and November 18, as the company reported underwhelming September-quarter results. Canopy disappointed investors with less-than-estimated revenue and earnings. Poor earnings of several other cannabis companies resulted in mayhem in the last week. Canopy…

Read More

E-Cigarette Statistics Show Why Cannabis Stocks Are Just Getting Started

E-cigarettes are currently roiled in controversy, albeit sales growth remains positive. Looking back, it’s amazing how quickly this industry emerged. In 2013, the global vaping market was worth just $4 billion. This year, it’s expected to approach $20 billion, which represents 500% growth in just six years. By 2023, Euromonitor International expects the market size to surpass $45 billion. Given…

Read More

Village Farms (TSX:VFF) Battles Joint Venture Partner: Could Both Cannabis Stocks Suffer?

Greenhouse farming expert Village Farms International’s (TSX:VFF)(NASDAQ:VFF) stock surged when it announced plans for cannabis production through a joint venture (JV) with technical partner Emerald Health Therapeutics (TSXV:EMH) in 2017, but rifts are emerging between the two partners and the situation could get ugly. Village Farms and EMH hold a 50% stake each in the Pure Sunfarms (PSF) joint venture…

Read More

Will Charlotte’s Web Holdings (TSX:CWEB) Stock Create Significant Shareholder Wealth?

We have seen the chaos in the cannabis sector over the last few months. Most cannabis stocks have lost 70% in market value, driven by lower-than-expected demand. The slow rollout of retail stores, competition from illegal sellers, and regulatory concerns have decimated pot stocks. But what if I told you one marijuana company has the potential to beat market returns?…

Read More

KALY – Kali-Extracts Confirms Cannabis Biopharmaceutical Capital Infusion Plans

Kali Extracts

DALLAS, Oct. 24, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today confirmed a recent conditional acquisition proposal from an investor interested in the acquisition of KALY’s Cannabis Extract Biopharmaceutical Technology. KALY CEO Frederick Ferri commented yesterday on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that the interest…

Read More

2 Reasons to Dump Aurora Cannabis (TSX:ACB) Stock Today

Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock is finally rebounding from its lowest point this year. At the time of writing, the stock is up 6.6% at market open. This relief rally comes after the company shed 36% of its value over the past six days.  Part of the reason for the turnaround is the fact that legislators in the United States seem…

Read More

Canopy Growth (TSX:WEED) Stock Surges: Should You Buy the Bounce?

Bargain hunters are finally piling into the troubled cannabis sector, and investors who have been on the sidelines during the 2019 rout are wondering if this is the right time to add pot stocks to their portfolios. Let’s take a look at Canopy Growth (TSX:WEED)(NYSE:CGC) to see if it deserves to be on your buy list right now. Volatility continues…

Read More

New Cannabis Data Proves Why This Market Is Still Heading Higher

The cannabis market has gone cold — or at least the stocks have. This year, most marijuana ETFs are down more than 50%. Stocks of both big and small companies alike have cratered. Nearly every competitor has been impacted. This type of contraction is commonplace in emerging markets. According to the Gartner hype cycle, a well-known tool for predicting the…

Read More

KALY – Kali-Extracts Introduces Third Option To Compete With Two $50 Million Acquisition Offers

DALLAS, Nov. 20, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced introducing a third option to compete with the two acquisition offers currently being entertained by KALY management. KALY has recently announced receiving two inquiries into the acquisition of the company’s cannabis biopharmaceutical technology valuing the technology at…

Read More